<DOC>
	<DOCNO>NCT01187589</DOCNO>
	<brief_summary>This study aim find effect PulseHalerâ„¢ Albuterol Lung Deposition Aerosol Pulmonary Functions COPD Patients</brief_summary>
	<brief_title>PulseHaler Drug Deposition Study Chronic Obstructive Pulmonary Disease Patients</brief_title>
	<detailed_description />
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Albuterol</mesh_term>
	<criteria>Diagnosis Chronic Obstructive Pulmonary Disease ( COPD ) , establish least 1 year Postbronchodilator FEV1/FVC &lt; 0.7 Postbronchodilator FEV1 range 30 % 70 % predicted Age : 40 year old Patient sign informed consent form Pneumothorax past , per anamnesis . Women age fertility , pregnant , plan pregnancy , use contraceptive . Severe cardiac disease , e.g. , Congestive Heart Failure ( CHF ) grade 3 high Coronary Artery Bypass Graft ( CABG ) Acute Myocardial Infarction ( MI ) within last 3 month Other severe systemic disease Noncooperative noncompliant patient</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>September 2011</verification_date>
</DOC>